Description

16th European Post-Chicago Melanoma / Skin Cancer Meeting 2026 (EPCM)

European Post-Chicago Melanoma / Skin Cancer Meeting (EPCM) 2026 – Hamburg, Germany

Access the complete 16th European Post-Chicago Melanoma / Skin Cancer Meeting (EPCM) 2026, one of Europe’s leading educational conferences dedicated to melanoma, non-melanoma skin cancers, immunotherapy, precision oncology, and dermatologic oncology.

Organized under the auspices of the Melanoma World Society (MWS) and the European Association of Dermato Oncology (EADO), this internationally recognized meeting brings together world-renowned experts to discuss the latest advances presented at ASCO 2026, cutting-edge clinical trials, emerging systemic therapies, personalized cancer treatment strategies, and evidence-based management of melanoma and skin cancer patients.

Whether you are a dermatologist, medical oncologist, surgical oncologist, radiation oncologist, dermatopathologist, or oncology trainee, this comprehensive educational package provides valuable clinical insights into modern melanoma care and multidisciplinary skin cancer management.

Who Should Watch?

This educational program is ideal for:

• Dermatologists
• Medical Oncologists
• Surgical Oncologists
• Radiation Oncologists
• Dermatopathologists
• Oncology Fellows
• Dermatology Residents
• General Surgeons
• Plastic Surgeons
• Cancer Researchers
• Healthcare Professionals involved in Skin Cancer Care

What You Will Learn

After completing this educational program, participants will be able to:

• Review the most important ASCO 2026 melanoma updates
• Understand advances in non-melanoma skin cancer management
• Improve early detection using dermoscopy
• Apply the newest EADO 2026 clinical guidelines
• Evaluate Gene Expression Profiling (GEP) in melanoma
• Understand modern immune checkpoint inhibitor (ICI) strategies
• Manage immunotherapy-related adverse events
• Treat vulnerable patient populations including elderly and immunocompromised patients
• Optimize treatment sequencing for melanoma
• Understand personalized oncology approaches
• Apply neoadjuvant and adjuvant melanoma therapies
• Review the latest advances in Merkel Cell Carcinoma
• Learn about Metastatic Uveal Melanoma
• Understand the role of ImmTACs, Tebentafusp and emerging bi-specific therapies
• Explore current evidence regarding the abscopal effect of radiotherapy

Course Topics

ASCO 2026 Highlights

• Melanoma
• Non-Melanoma Skin Cancer

Dermoscopy

• Dermoscopy for detection of all skin cancers
• Early diagnosis strategies

Lifestyle & Cancer Outcomes

• Exercise
• Nutrition
• Timing of Immune Checkpoint Inhibitor Administration

Merkel Cell Carcinoma

• Adjuvant Trials
• Neoadjuvant Therapy
• Radiotherapy
• Advanced Disease Management

Vulnerable Skin Cancer Patients

• Family Planning
• Elderly & Frail Patients
• Immunocompromised Patients

Immune Checkpoint Inhibitor Toxicity

• Long-term Toxicities
• Delayed Immune Toxicities
• Rechallenge Strategies
• Immunosuppressive Therapy

Gene Expression Profiling (GEP)

• Best GEP Tests
• Oncotype DX Comparison
• Clinical Implementation
• Future Guidelines

EADO Guidelines 2026

• Basal Cell Carcinoma (BCC)
• Cutaneous Squamous Cell Carcinoma (CSCC)
• Current Clinical Trials
• Future Treatment Strategies

Novel Immunotherapies

• ImmTACs
• Tebentafusp
• Brenetafusp
• Metastatic Uveal Melanoma
• Cutaneous Melanoma

Personalized Oncology

• Precision Medicine
• Biomarker Guided Therapy
• Future of Individualized Cancer Care

Melanoma Treatment

• Neoadjuvant Therapy
• Perioperative Treatment
• Adjuvant Immunotherapy
• Targeted Therapy
• Immune Checkpoint Inhibitors
• BRAF Mutated Melanoma

Radiotherapy

• Abscopal Effect
• Current Clinical Evidence

Satellite Symposia

• Metastatic Uveal Melanoma
• Cutaneous Squamous Cell Carcinoma
• Early Stage Melanoma
• Individualized Therapy
• Redefining Melanoma Care
• Merkel Cell Carcinoma Immunotherapy

Why This Course?

This conference delivers one of the most comprehensive reviews of melanoma and skin cancer management in 2026, combining the latest ASCO highlights, EADO guideline updates, precision oncology, immunotherapy, targeted therapy, gene expression profiling, Merkel Cell Carcinoma, cutaneous squamous cell carcinoma, basal cell carcinoma, and uveal melanoma into a single educational resource.

Healthcare professionals will gain practical knowledge that can immediately improve patient care while staying current with rapidly evolving advances in dermatologic oncology.